Wilmington, DE, United States of America

Alan Martin Allgeier

USPTO Granted Patents = 27 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 170(Granted Patents)

Location History:

Oak Park, CA (US) (2007 - 2012)
Wilmington, DE (US) (2001 - 2024)

Company Filing History:

16 out of 16,338

E.i. Dupont De Nemours and Company

patents

6 out of 395

Invista North America S.a.r.l.

Years Active: 2001-2025

Loading Chart...

27 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12221417 - Salt of omecamtiv mecarbil and process for preparing salt (2025-02-11),

2. 11958809 - Salt of omecamtiv mecarbil and process for preparing salt (2024-04-16),

3. 11472773 - Salt of omecamtiv mecarbil and process for preparing salt (2022-10-18),

4. 9988354 - Salt of omecamtiv mecarbil and process for preparing salt (2018-06-05),

5. 9670118 - Production of alpha, omega-diols (2017-06-06),

6. 9181157 - Production of alpha, omega-diols (2015-11-10),

7. 9018423 - Production of alpha, omega-diols (2015-04-28),

8. 8962894 - Process for preparing 1, 6-hexanediol (2015-02-24),

9. 8889922 - Process for preparing 1, 6-hexanediol (2014-11-18),

10. 8889912 - Process for preparing 1,6-hexanediol (2014-11-18),

11. 8865940 - Process for preparing 1,6-hexanediol (2014-10-21),

12. 8859826 - Production of alpha, omega-diols (2014-10-14),

13. 8846985 - Production of alpha, omega-diols (2014-09-30),

14. 8846984 - Production of α,ω-diols (2014-09-30),

15. 8183293 - Phenyl acetic acid derivatives (2012-05-22),

Title: Innovations and Achievements of Alan Martin Allgeier

Introduction

Alan Martin Allgeier is a notable inventor based in Wilmington, DE, USA, with a remarkable portfolio of 27 patents to his name. His work primarily focuses on pharmaceutical formulations and innovative methods that contribute significantly to the field of drug development.

Latest Patents

Among his latest contributions are patents centered around the compound omecamtiv mecarbil. These patents include "Salt of omecamtiv mecarbil and process for preparing salt," which provides valuable dihydrochloride salt forms, compositions, and pharmaceutical formulations, alongside methods for their preparation and use. This work showcases his dedication to advancing medical science through innovative pharmaceutical solutions.

Career Highlights

Throughout his career, Alan has been affiliated with prominent companies such as E.I. du Pont de Nemours and Company and Invista North America S.a.r.l. His roles within these organizations have allowed him to leverage his inventive skills and contribute to groundbreaking research and development in his field.

Collaborations

Alan's innovative journey has also been enriched through collaborations with peers such as Sourav Kumar Sengupta and Wathudura Indika Namal De Silva. These partnerships have facilitated knowledge exchange and enhanced the quality of the innovations he has been part of, leading to successful patent applications and contributions to research.

Conclusion

Alan Martin Allgeier stands out as a significant figure in the world of inventions and patents. His extensive experience, combined with his commitment to advancing pharmaceutical sciences, underscores the impact of collaborative innovation in addressing medical challenges. With his continuous contributions, he remains an influential inventor paving the way for future advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.